Effects of Autologous Immunotherapy on Islet Metabolism and T Cell Immunity in Type 2 Diabetic Rabbits
These findings suggest that ATIM ameliorates T2DM through synergistic regulation of metabolic pathways and immune balance, supporting its potential as a therapeutic approach targeting both metabolic and immune dysfunction in T2DM.
Authors
- Aihua Jiang
- Zhimei Huang (ORCID: https://orcid.org/0000-0002-4532-1970)
- Liu Yinglan
- Lan Zhang (ORCID: https://orcid.org/0000-0002-7572-1035)
- Jiaqi Chen
- Jianping Wang
- Fenglei Yu
Institutions
- Central South University (CN)
- Shenzhen Metro (China) (CN)
- Hunan Cancer Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- University of South China (CN)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.2174/0113892010398198251129103628
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00